The highest story in endocrinology final week centered on medical suppliers’ work-life steadiness and using self-care to scale back work-related burnout.
C. Nicole Swiner, MD, chief govt officer of Serenity Hydration & Wellness in Durham, North Carolina, and previously a founding accomplice and household doctor at Durham Household Medication, mentioned that receiving assist from assist employees, taking trip and psychological well being days when wanted, and constructing a community of allies and mentors can assist cut back stress and enhance well-being.
One other high story was concerning the FDA approval of Mounjaro (tirzepatide, Eli Lilly) — a first-in-class medication that prompts each the GLP-1 and glucose-dependent insulinotropic polypeptide receptors — as a therapy to assist enhance glucose response in adults with sort 2 diabetes.
Learn these and extra high tales in endocrinology under:
Higher deal with self-care can cut back burnout, enhance work-life steadiness for suppliers
Medical suppliers can cut back work-related burnout by focusing extra on self-care and work-life steadiness, in response to a speaker on the AACE Annual Scientific and Medical Convention. Read more.
FDA approves tirzepatide, first twin incretin agonist for sort 2 diabetes
The FDA introduced it authorized the injectable twin incretin agonist tirzepatide to enhance glucose response in adults with sort 2 diabetes along with eating regimen and train. Read more.
Higher adrenal gland quantity seen for adults with vs. with out sort 2 diabetes
Adrenal gland quantity is bigger amongst adults with sort 2 diabetes than with out diabetes and may function a biomarker of metabolic standing, in response to research findings. Read more.
VIDEO: Verify thyroid autoimmunity for girls with infertility
On this video, Trevor E. Angell, MD, talks with Caroline T. Nguyen, MD, concerning the relationship between thyroid autoimmunity and girls’s fertility. Read more.
VIDEO: AACE tailors new fatty liver guideline to endocrinologists
On this video, Jonathan D. Leffert, MD, and Kenneth Cusi, MD, FACP, FACE, focus on the brand new American Affiliation of Medical Endocrinology nonalcoholic fatty liver illness guideline tailor-made for endocrinologists. Read more.